Trevi Therapeutics (TRVI) Short-term Investments (2022 - 2026)
Trevi Therapeutics' Short-term Investments came in at $264.57 million for Q2 2026, up 204.7% from $86.83 million a year earlier and up 73.6% from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Short-term Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Trevi Therapeutics' Short-term Investments was $169.35 million, up 130.3% from FY2024.
- Short-term Investments carries a three-year compound annual growth rate of 16.2% (FY2022 to FY2025).
- Going back by year, Short-term Investments was $73.53 million in FY2024 (+45.4%), $50.57 million in FY2023 (-53.1%) and $107.92 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Short-term Investments in data going back to Q2 2022.
- Year-over-year, Short-term Investments has increased for seven consecutive quarters, with growth averaging 89.5% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q2 2026 (growth of 204.7%), and the weakest in Q4 2023 (a decline of 53.1%).
- Business Quant data shows TRVI's Short-term Investments at $152.37 million (Q1 2026), $169.35 million (Q4 2025) and $138.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Trevi Therapeutics | 1.84 Bn | 969.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 264.57 Mn |
| Mar 31, 2026 | 152.37 Mn |
| Dec 31, 2025 | 169.35 Mn |
| Sep 30, 2025 | 138.06 Mn |
| Jun 30, 2025 | 86.83 Mn |
| Mar 31, 2025 | 83.88 Mn |
| Dec 31, 2024 | 73.53 Mn |
| Sep 30, 2024 | 49.44 Mn |
| Jun 30, 2024 | 56.53 Mn |
| Mar 31, 2024 | 59.01 Mn |
| Dec 31, 2023 | 50.57 Mn |
| Sep 30, 2023 | 62.90 Mn |
| Jun 30, 2023 | 80.40 Mn |
| Mar 31, 2023 | 99.61 Mn |
| Dec 31, 2022 | 107.92 Mn |
| Sep 30, 2022 | 59.03 Mn |
| Jun 30, 2022 | 53.16 Mn |
API Access
Trevi Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();